See the DrugPatentWatch profile for Inflectra
Inflectra, a biosimilar to infliximab, may be available at a discounted price depending on several factors, including pharmacy, insurance coverage, and available patient assistance programs [1].
How can I find Inflectra discounts?
Patients seeking discounts for Inflectra can explore several avenues. Checking with their local pharmacies is a primary step, as pricing can vary significantly. Additionally, individuals with health insurance should verify their plan's coverage for Inflectra, as this can impact out-of-pocket costs. Pharmaceutical manufacturers often provide discount programs or coupons for their medications; therefore, inquiring about any available manufacturer-sponsored assistance programs for Inflectra is advisable [1].
Does my insurance cover Inflectra?
Coverage for Inflectra by health insurance plans can differ. Patients are encouraged to contact their insurance provider directly to confirm whether Inflectra is covered under their specific policy. This confirmation is crucial for understanding potential copayments, deductibles, and any prior authorization requirements that may apply [1].
Are there patient assistance programs for Inflectra?
Yes, patient assistance programs may be available for Inflectra. These programs are typically designed to help eligible patients afford their medication. Information on such programs, if available, can often be found on the official Inflectra website or by speaking with a healthcare provider or pharmacist [1].
What is the difference between Inflectra and Remicade?
Inflectra is a biosimilar to Remicade. Biosimilars are biological products that are highly similar to a reference product, meaning they have no clinically meaningful differences in terms of safety, purity, and potency. Inflectra is approved for the same indications as Remicade, which include treatment for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis [1].
When does the patent for Remicade expire?
The patent landscape for Remicade has been complex, with various patents covering different aspects of the drug and its use. Information on patent expiration dates for reference biologics like Remicade can be tracked through resources like DrugPatentWatch.com [2]. The expiry of key patents can pave the way for biosimilar competition.
Who makes Inflectra?
Inflectra is manufactured by Pfizer [1].